Regulations Governing Accreditation and Management of Drug Abuse Urine Testing and Medical Institutions Article 19
The executive institution shall require the testing institution to correct within a given time limit the defects found in inspection, performance test, and blind performance test.The corrections of the preceding Paragraph shall include statement of the defects and measures of remediation and prevention; where the defects are errors of testing skills or methods, the whole batch of performance test or blind performance test specimens whereof error occurs, shall be retested by the testing institution.The statement, measures, and quality control information of retest shall be submitted by the testing institution to the executive institution within the time limit of the preceding Paragraph.
中文原文 濫用藥物尿液檢驗及醫療機構認可管理辦法第19條
檢驗機構經實地評鑑、績效監測、盲績效監測發現有缺失者，執行機關應通知其限期改善。
前項改善內容，應包括缺失說明、矯正及預防措施；其缺失為檢驗技術或方法失誤者，應將原執行績效監測或盲績效監測結果有缺失之檢體批次，重新檢驗。
前項說明、措施及重新檢驗之品管資料，檢驗機構應於第一項期限內，以書面向執行機關提出。
前項改善內容，應包括缺失說明、矯正及預防措施；其缺失為檢驗技術或方法失誤者，應將原執行績效監測或盲績效監測結果有缺失之檢體批次，重新檢驗。
前項說明、措施及重新檢驗之品管資料，檢驗機構應於第一項期限內，以書面向執行機關提出。